Methodological concerns: evaluating central nervous system (CNS) active compounds in Alzheimer's disease (AD).
Cutler
N R
NR
Center for Aging & Alzheimer's, Beverly Hills, California 90211.
D000544:Alzheimer Disease / Q000188:drug therapy*; D002491:Central Nervous System Agents / Q000627:therapeutic use*; D002985:Clinical Protocols; D006801:Humans; D012107:Research Design
D002491:Central Nervous System Agents